News
IDT Biologika has launched its first swine influenza vaccine to protect against all three subtypesDessau-Rosslau, 23 March 2010 - In January of this year, IDT Biologika launched its swine influenza vaccine RESPIPORC FLU3, the first registered vaccine on the market to protect pigs against all three, most recent and clinically significant subtypes of the influenza virus H1N1, H3N2 and H1N2. |
IDT Biologika to Emphasize Expanding Biopharmaceutical Service and Production Capability at CPhI/ICSE 2009Dessau-Rosslau, 25 September 2009 - IDT Biologika will highlight a growing global presence and enhanced vaccine production capabilities at the 2009 International Contract Services Exhibition (CPhI/ICSE) in Madrid. |
IDT Biologika Establishes New Corporation in the United StatesDessau-Rosslau, 1 June 2009 - Rising demand for services prompts European biologics-based manufacturer of sterile liquid dosage forms and innovative vaccines to establish operations in Northern Virginia. |
IDT Biologika Starts Up Ultra-High Speed Packaging Line for Sterile Liquid Dosage FormsDessau-Rosslau, 23 February 2009 - Increase in demand for injectables prompts construction of state-of-the-art facility capable of packaging up to 30 million syringes per year. The new packaging line for sterile liquid dosage forms went online in January 2009. |
IDT Biologika expands Packaging Capability for Prefilled SyringesDessau-Rosslau, 30 September 2008 - IDT has expanded its capability for the packaging of sterile liquid dosage pharma-ceuticals in prefilled syringes. The move was made in response to increased demand for company's fully-integrated services. |
IDT Biologika received the Facility of the Year Award for Operational ExcellenceDessau-Rosslau, 26 March 2008 - The Facility of the Year Awards program recognizes state-of-the-art pharmaceutical manufaturing projects that utilize new and innovative technologies to enhance quality and reduce the cost of producing medicines. |
